The mission of Spectrum, the CTSA-supported independent research center at Stanford, is to transform the academic enterprise to optimally support clinical and translational research and education (CTRE). Spectrum's programs are designed to extend from the earliest phase of basic discovery to final implementation of these discoveries in the population. The ultimate goals of our efforts are to streamline the translation of basic innovations into practical solutions that maintain and improve human health, and to educate the next generation of CTR leaders. In the next five years. Spectrum will leverage institutional strengths to nurture our entrepreneurial researchers to efficiently transfer discoveries from the laboratory to the bedside and into the community. The CTSA will provide critical resources, services and educational opportunities to ensure progress toward this mission.
The specific aims of Spectrum are: 1) Educate the next generation of investigators with the multidisciplinary skills required to conduct cutting- edge clinical and translational research to meet the opportunities and challenges of medicine in the 21st century. Spectrum will facilitate the transformation of medical research training from a narrow focus on discipline-restricted expertise to a more interdisciplinary team approach where trainees become conversant in the language, processes and tools used across the full extent of the translational pipeline (T1-T4). 2) Create an institutional home conducive to efficiently translating the most innovative discoveries made by our basic, translational and clinical scientists into products and processes that directly improve human health and well-being. Spectrum will provide the institutional environment to identify and then support those discoveries that are most ready for translation. 3) Develop and implement CTRE resources and services to accelerate the translation of discoveries into better human health, while simultaneously reducing operating costs. Spectrum will ensure that investigators receive the necessary clinical trial, informatics, statistics, regulatory, ethics and administrative support to maximize their research productivity, and optimize the participation of diverse populations.

Public Health Relevance

The mission of Spectrum, Stanford's CTSA-supported center, is to transform the enterprise to best support discovery, innovation and education in clinical and translational research across the university. Spectrum's programs extend from the earliest phase of basic discovery to final implementation in the population, with an ultimate goal of strengthening healthcare and improving cost efficiencies.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001085-05
Application #
9268094
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S2))
Program Officer
Talbot, Bernard
Project Start
2013-09-26
Project End
2018-04-30
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
5
Fiscal Year
2017
Total Cost
$7,613,082
Indirect Cost
$2,760,333
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Wilkinson, Adam C; Morita, Maiko; Nakauchi, Hiromitsu et al. (2018) Branched-chain amino acid depletion conditions bone marrow for hematopoietic stem cell transplantation avoiding amino acid imbalance-associated toxicity. Exp Hematol 63:12-16.e1
Kahn, Suzana A; Wang, Xin; Nitta, Ryan T et al. (2018) Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nat Commun 9:4121
Avati, Anand; Jung, Kenneth; Harman, Stephanie et al. (2018) Improving palliative care with deep learning. BMC Med Inform Decis Mak 18:122
Zhao, Chen; Viana Jr, Alonço; Ma, Yifei et al. (2018) The effect of aging on drug-induced sleep endoscopy findings. Laryngoscope 128:2644-2650
Burgener, Elizabeth B; Moss, Richard B (2018) Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis. Curr Opin Pediatr 30:372-377
Ho, Annabell; Hancock, Jeff; Miner, Adam S (2018) Psychological, Relational, and Emotional Effects of Self-Disclosure After Conversations With a Chatbot. J Commun 68:712-733
Girsen, Anna I; Mayo, Jonathan A; Wallenstein, Matthew B et al. (2018) What factors are related to recurrent preterm birth among underweight women? J Matern Fetal Neonatal Med 31:560-566
Forlenza, Gregory P; Raghinaru, Dan; Cameron, Faye et al. (2018) Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents. Pediatr Diabetes 19:420-428
Mello, Michelle M; Lieou, Van; Goodman, Steven N (2018) Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing. N Engl J Med 378:2202-2211
Pu, Szu-Yuan; Wouters, Randy; Schor, Stanford et al. (2018) Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity. J Med Chem :

Showing the most recent 10 out of 406 publications